Download presentation
Presentation is loading. Please wait.
Published byἈριστόδημε Πρωτονοτάριος Modified over 6 years ago
1
Antagonists in poor-responder patients
Alan B. Copperman, M.D. Fertility and Sterility Volume 80, Pages (July 2003) DOI: /S (03)
2
FIGURE 1 Relationship among age, declining pregnancy rates, and a rising prevalence of poor ovarian responsiveness. Copperman. GnRH antagonist in poor-responding patients.Fertil Steril 2003. Fertility and Sterility , 16-24DOI: ( /S (03) )
3
FIGURE 2 Clinical pregnancy rates relative to ovarian response and age in IVF. Copperman. GnRH antagonist in poor-responding patients.Fertil Steril 2003. Fertility and Sterility , 16-24DOI: ( /S (03) )
4
FIGURE 3 High-dose gonadotropins are associated with poor pregnancy outcomes after IVF. Copperman. GnRH antagonist in poor-responding patients.Fertil Steril 2003. Fertility and Sterility , 16-24DOI: ( /S (03) )
5
FIGURE 4 Clinical pregnancy rates relative to duration of gonadotropin stimulation. Copperman. GnRH antagonist in poor-responding patients.Fertil Steril 2003. Fertility and Sterility , 16-24DOI: ( /S (03) )
6
FIGURE 5 Oral contraceptive pretreatment (OCP) is associated with improved cycle characteristics in IVF. Copperman. GnRH antagonist in poor-responding patients.Fertil Steril 2003. Fertility and Sterility , 16-24DOI: ( /S (03) )
7
FIGURE 6 Patients who were cancelled for poor response in a prior assisted reproductive technology (ART) cycle. Copperman. GnRH antagonist in poor-responding patients.Fertil Steril 2003. Fertility and Sterility , 16-24DOI: ( /S (03) )
8
FIGURE 7 Pregnancy rates in GnRH antagonist-treated cycles in patients with low and normal BAF counts. Copperman. GnRH antagonist in poor-responding patients.Fertil Steril 2003. Fertility and Sterility , 16-24DOI: ( /S (03) )
9
FIGURE 8 Comparison of cycle outcomes in patients with low BAF counts treated with GnRH antagonist or microdose flare agonist protocol. Copperman. GnRH antagonist in poor-responding patients.Fertil Steril 2003. Fertility and Sterility , 16-24DOI: ( /S (03) )
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.